Insulin glargine and lixisenatide and Lo/Ovral-28
Determining the interaction of Insulin glargine and lixisenatide and Lo/Ovral-28 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: ethinyl estradiol / norgestrel
Brand name: Cryselle 28, Low-Ogestrel, Ogestrel-28, Cryselle-28, Elinest, Ogestrel, Lo/Ovral-21, Lo/Ovral-28, Ovral, Ovral-28, Low-Ogestrel-21, Ovral-21
Synonyms: Lo/Ovral-28 (Oral), Lo Ovral 28
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Locoid
- Insulin glargine and lixisenatide-Locoid Cream
- Insulin glargine and lixisenatide-Locoid Lipocream
- Insulin glargine and lixisenatide-Locoid Lipocream Topical application
- Insulin glargine and lixisenatide-Locoid Lotion
- Insulin glargine and lixisenatide-Locoid Ointment
- Lo/Ovral-28-Insulin glargine and lixisenatide Subcutaneous
- Lo/Ovral-28-Insulin glargine, recombinant Subcutaneous
- Lo/Ovral-28-Insulin glulisine
- Lo/Ovral-28-Insulin Glulisine (Cartridges and Pens)
- Lo/Ovral-28-Insulin Glulisine (Vials)
- Lo/Ovral-28-Insulin glulisine Subcutaneous